TITLE

Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations

AUTHOR(S)
Hanekom, Willem A.; Dockrell, Hazel M.; Ottenhoff, Tom H. M.; Doherty, T. Mark; Fletcher, Helen; McShane, Helen; Weichold, Frank F.; Hoft, Dan F.; Parida, Shreemanta K.; Fruth, Uli J.
PUB. DATE
July 2008
SOURCE
PLoS Medicine;Jul2007, Vol. 5 Issue 7, pe145
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Willem Hanekom and colleagues make recommendations on assay harmonization for novel tuberculosis vaccine trials.
ACCESSION #
33410285

 

Related Articles

  • New TB vaccine approach shows promise in mice.  // Biomedical Market Newsletter;9/12/2011, Vol. 21, p156 

    The article reports on the result of the study which revealed that an experimental vaccine composed of a genetically modified bacterium has been found to protect mice against tuberculosis (TB) infection. It mentions that the World Health Organization (WHO) has estimated 1.7 million people who...

  • Good Clinical Laboratory Practices Improved Proficiency Testing Performance at Clinical Trials Centers in Ghana and Burkina Faso. Ibrahim, Faisal; Dosoo, David; Kronmann, Karl C.; Ouedraogo, Issa; Anyorigiya, Thomas; Abdul, Haruna; Sodiomon, Sirima; Owusu-Agyei, Seth; Koram, Kwadwo // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    Background: The recent drive towards accreditation of clinical laboratories in Africa by the World Health Organization - Regional Office for Africa (WHO-AFRO) and the U.S Government is a historic step to strengthen health systems, provide better results for patients and an improved quality of...

  • Is belief larger than fact: expectations, optimism and reality for translational stem cell research. Bubela, Tania; Li, Matthew D.; Hafez, Mohamed; Bieber, Mark; Atkins, Harold // BMC Medicine;2012, Vol. 10 Issue 1, p133 

    Background: Stem cell (SC) therapies hold remarkable promise for many diseases, but there is a significant gulf between public expectations and the reality of progress toward clinical application. Public expectations are fueled by stakeholder arguments for research and public funding, coupled...

  • Lack of efficacy of MVA85A TB vaccine candidate: potential outcomes. KENNETH, JOHN // Current Science (00113891);6/25/2013, Vol. 104 Issue 12, p1594 

    A letter to the editor is presented regarding a clinical trial in Cape Town, South Africa which revealed the lack of efficacy of a tuberculosis (TB) vaccine.

  • Vaccinating against cervical cancer. Parry, Jane // Bulletin of the World Health Organization;Feb2007, Vol. 85 Issue 2, p89 

    The article presents information on the measures taken for the treatment of cervical cancer in developing countries such as Africa. Although the human papillomavirus (HPV) vaccine has been found useful for reducing cervical cancer, the health care professionals face tough decisions. Lack of...

  • Tuberculosis in Malta and the school BCG vaccination programme. Farrugia, Brian; Sant'Angelo, Victoria; Cacciottolo, Joseph // Malta Medical Journal;Jun2009, Vol. 21 Issue 2, p13 

    Background: Malta has one of the lowest incidence rates of tuberculosis in Europe and a comprehensive free-of-charge health care system. Objective: To investigate whether Malta satisfies the criteria recommended by the International Union Against Tuberculosis and Lung Disease (IUATLD) in order...

  • WHO clinical trial registration initiative.  // WHO Drug Information;2005, Vol. 19 Issue 2, p126 

    Reports that the World Health Organization has established an international clinical trial registration. Framework for the development of the international clinical trial registration form; Basic provisions of the initiative; Registration data set.

  • Wider participation required in HIV vaccine clinical trials.  // Weekly Epidemiological Record;9/3/2004, Vol. 79 Issue 36, p326 

    The article presents information on a meeting, organized by WHO and the Joint United Nations Programme on HIV/AIDS (UNAIDS). The meeting brought together for the first time 40 experts from around the world to address the issues of gender and age, in particular, as well as race in HIV...

  • Industry anger over stringent trial disclosure requirements. Wadman, Meredith // Nature Reviews Drug Discovery;Jul2006, Vol. 5 Issue 7, p527 

    The article focuses on the argument over the World Health Organization's (WHO) request to register early stage trials. In an attempt to harmonize the process, the WHO has published universal standards for revealing data of clinical trials. The new standards endorse registration of all trials...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics